HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 45 - 50)

Take-home naloxone carriage among opioid users in Lanarkshire

Hill D.R., Al Azizi B., Conroy S., and Akram G.

Summary: Background: Naloxone has been used widely as a means of reducing opioid overdose related deaths. Despite the wide distribution of naloxone kits among drug users, limited understanding exists as to how naloxone is perceived and carried amongst different populations of drug users. Aims: To assess naloxone carriage rate among drug users in Lanarkshire, Scotland. To additionally examine drug users' knowledge about wider aspects associated with naloxone use and storage. Methods: A cross sectional survey of addiction service users, using a 10 item semi structured questionnaire which was administered by addiction service workers during autumn 2016. Results: 310 individuals were surveyed. The majority (n=179, 58%) had retained the naloxone supplied to them. 21 reported to be carrying their naloxone at interview (11.3%), 43 (24%) reported not having their naloxone available the last time they used drugs. When asked where their naloxone supply was, the most commonly reported place for storing their naloxone was ‘Home' (n= 129, 72.1%). Conclusion: The low carriage rate of naloxone among drug users suggests that wide distribution and current training programmes are not being sufficiently heeded and for take-home naloxone programmes to succeed, further research at both individual and system levels, is required.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page